Professional Documents
Culture Documents
Pregnancy Category C
Drug classes
Antisecretory agent
Proton pump inhibitor
Therapeutic actions
Gastric acid-pump inhibitor: Suppresses gastric acid secretion by specific inhibition of
the hydrogen-potassium ATPase enzyme system at the secretory surface of the gastric
parietal cells; blocks the final step of acid production.
Indications
Short-term treatment of active duodenal ulcer
First-line therapy in treatment of heartburn or symptoms of gastroesophageal
reflux disease (GERD)
Short-term treatment of active benign gastric ulcer
GERD, severe erosive esophagitis, poorly responsive symptomatic GERD
Long-term therapy: Treatment of pathologic hypersecretory conditions (Zollinger-
Ellison syndrome, multiple adenomas, systemic mastocytosis)
Eradication of H. pylori with amoxicillin or metronidazole and clarithromycin
Prilosec OTC: Treatment of frequent heartburn (2 or more days per wk)
Unlabeled use: Posterior laryngitis; enhance efficacy of pancreatin for the
treatment of steatorrhea in cystic fibrosis
Available forms
DR capsules—10, 20, 40 mg; DR tablets—20 mg (OTC)
Dosages
ADULTS
Active duodenal ulcer: 20 mg PO daily for 4–8 wk. Should not be used for
maintenance therapy.
Active gastric ulcer: 40 mg PO daily for 4–8 wk.
Severe erosive esophagitis or poorly responsive GERD: 20 mg PO daily for 4–8
wk. Do not use as maintenance therapy. An additional 4–8 wk course can be
considered if needed.
Pathologic hypersecretory conditions: Individualize dosage. Initial dose is 60 mg
PO daily. Doses up to 120 mg tid have been used. Administer daily doses of >
80 mg in divided doses.
Frequent heartburn (2 or more days/wk): 20 mg (Prilosec OTC tablet) PO once
daily before eating in the AM for 14 days. May repeat the 14-day course q 4 mo.
PEDIATRIC PATIENTS
Safety and efficacy not established.
Pharmacokinetics
Route Onset Peak
Oral Varies 0.5–3.5 hr
Adverse effects
CNS: Headache, dizziness, asthenia, vertigo, insomnia, apathy, anxiety,
paresthesias, dream abnormalities
Dermatologic: Rash, inflammation, urticaria, pruritus, alopecia, dry skin
GI: Diarrhea, abdominal pain, nausea, vomiting, constipation, dry mouth, tongue
atrophy
Respiratory: URI symptoms, cough, epistaxis
Other: Cancer in preclinical studies, back pain, fever
Interactions
Drug-drug
Increased serum levels and potential increase in toxicity of benzodiazepines,
phenytoin, warfarin; if these combinations are used, monitor patient very closely
Decreased absorption with sucralfate; give these drugs at least 30 min apart
Nursing considerations
Assessment
History: Hypersensitivity to omeprazole or any of its components; pregnancy,
lactation
Physical: Skin lesions; T; reflexes, affect; urinary output, abdominal exam;
respiratory auscultation
Interventions
Administer before meals. Caution patient to swallow capsules whole—not to
open, chew, or crush them.
Arrange for further evaluation of patient after 8 wk of therapy for gastroreflux
disorders; not intended for maintenance therapy. Symptomatic improvement does
not rule out gastric cancer, which did occur in preclinical studies.
Administer antacids with omeprazole, if needed.
Teaching points
Take the drug before meals. Swallow the capsules whole; do not chew, open, or
crush them. This drug will need to be taken for up to 8 wk (short-term therapy) or
for a prolonged period (> 5 yr in some cases).
Have regular medical follow-up visits.
These side effects may occur: Dizziness (avoid driving or performing hazardous
tasks); headache (request medications); nausea, vomiting, diarrhea (maintain
proper nutrition); symptoms of upper respiratory tract infection, cough (do not
self-medicate; consult with your health care provider if uncomfortable).
Report severe headache, worsening of symptoms, fever, chills.
Adverse effects in Italic are most common; those in Bold are life-threatening.